These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 12626949)

  • 21. Screening for prostate cancer in a population of South Poland--studies 2000.
    Laskiewicz J; Janik A; Dobrek Ł; Słodowska-Hajduk Z; Matyja A; Thor PJ
    Folia Med Cracov; 2003; 44(1-2):159-68. PubMed ID: 15232898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for prostate cancer.
    Brawley OW; Ankerst DP; Thompson IM
    CA Cancer J Clin; 2009; 59(4):264-73. PubMed ID: 19564245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.
    Andriole GL; Levin DL; Crawford ED; Gelmann EP; Pinsky PF; Chia D; Kramer BS; Reding D; Church TR; Grubb RL; Izmirlian G; Ragard LR; Clapp JD; Prorok PC; Gohagan JK;
    J Natl Cancer Inst; 2005 Mar; 97(6):433-8. PubMed ID: 15770007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The prostate specific antigen: what can we learn from the American experience?].
    Zhao XJ
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3313-5. PubMed ID: 16409833
    [No Abstract]   [Full Text] [Related]  

  • 25. Prostate cancer screening; is this a teachable moment?
    Brawley OW
    J Natl Cancer Inst; 2009 Oct; 101(19):1295-7. PubMed ID: 19720970
    [No Abstract]   [Full Text] [Related]  

  • 26. Screening for prostate cancer: is it worthwhile?
    Hudson MA
    Contemp Urol; 1994 Mar; 6(3):37, 41-9. PubMed ID: 10146749
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical practice. Screening for prostate cancer.
    Hoffman RM
    N Engl J Med; 2011 Nov; 365(21):2013-9. PubMed ID: 22029754
    [No Abstract]   [Full Text] [Related]  

  • 28. Prostate-specific antigen levels in the United States: implications of various definitions for abnormal.
    Welch HG; Schwartz LM; Woloshin S
    J Natl Cancer Inst; 2005 Aug; 97(15):1132-7. PubMed ID: 16077071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mass screening for prostate cancer. The Swedish Council on Technology Assessment in Health Care.
    Int J Cancer Suppl; 1996; 9():1-72. PubMed ID: 8982323
    [No Abstract]   [Full Text] [Related]  

  • 30. Screening for prostate cancer: who and how often?
    Schwartz K; Deschere B; Xu J
    J Fam Pract; 2005 Jul; 54(7):586-96. PubMed ID: 16009085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate cancer as a public health issue in North Carolina.
    Stark N; Paskett E; Demark-Wahnefried W; Carbone E; Godley P
    N C Med J; 2001; 62(5):286-90. PubMed ID: 11570328
    [No Abstract]   [Full Text] [Related]  

  • 32. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
    Agalliu I; Weiss NS; Lin DW; Stanford JL
    Cancer Causes Control; 2007 Nov; 18(9):931-7. PubMed ID: 17641982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of prostate-specific antigen in prostate cancer.
    Liang SL
    MLO Med Lab Obs; 2008 Oct; 40(10):54, 56-7. PubMed ID: 18988558
    [No Abstract]   [Full Text] [Related]  

  • 34. Non-systematic screening for prostate cancer in Sweden--survey from the National Prostate Cancer Registry.
    Stattin P; Johansson R; Damber JE; Hellström M; Hugosson J; Lundgren R; Varenhorst E; Johansson JE
    Scand J Urol Nephrol; 2003; 37(6):461-5. PubMed ID: 14675917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumour markers in prostate cancer: EGTM recommendations. European Group on Tumour Markers.
    Anticancer Res; 1999; 19(4A):2799-801. PubMed ID: 10470244
    [No Abstract]   [Full Text] [Related]  

  • 36. Prostate cancer and prostate-specific antigen: facts, figures and commentary.
    Chambers DC
    J Insur Med; 1993; 25(3):336-40. PubMed ID: 10146433
    [No Abstract]   [Full Text] [Related]  

  • 37. Prostate cancer. Primary care providers play critical role.
    Holden J; Emery CB
    Adv Nurse Pract; 2004 Apr; 12(4):28-35; quiz 36. PubMed ID: 15101132
    [No Abstract]   [Full Text] [Related]  

  • 38. Incidental acute prostatic inflammation is associated with a lower percentage of free prostate-specific antigen than other benign conditions of the prostate: a prospective screening study.
    Rowe EW; Laniado ME; Walker MM; Anup P
    BJU Int; 2006 May; 97(5):1039-42. PubMed ID: 16643488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [About Psa-screening].
    Hakama M; Auvinen A; Stenman UH; Tammela T
    Duodecim; 1996; 112(14):1314-6. PubMed ID: 10596108
    [No Abstract]   [Full Text] [Related]  

  • 40. [Screening of the prostate cancer. "lnstantaneous" of a daily practice among 300 general practitioners of the canton of Vaud].
    Praz V; Jichlinski P; Aymon D; Leisinger HJ
    Rev Med Suisse; 2005 Dec; 1(44):2840-2. PubMed ID: 16382715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.